Astellas and Seagen's Padcev is on course to move further up the treatment pathway in bladder cancer, thanks to a positive readout in the EV-103 clinical trial. The latest results come from cohort H ...
Morningstar Data+Analytics combines our renowned independent research and ratings with coverage and analysis of the expanding universe of investment opportunities. Reveal actionable insights about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback